Plumeria Therapeutics, Inc.
PrivateLast Round
Grant
Oct 30, 2025
Total Funding Raised
$3.97M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Plumeria Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in New Jersey. Its latest recorded funding round was a Grant round in October 2025.
Plumeria Therapeutics, Inc. is a clinical-stage biotechnology company developing non-opioid pain treatments and companion diagnostics for chronic pain conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Plumeria Therapeutics, Inc. Comparables
Compare Plumeria Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novaremed AG | 79% | |
| Latigo Biotherapeutics | 79% | |
| EicOsis Human Health, Inc. | 78% |
For institutional investors. Book with your work email.
Plumeria Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 30, 2025 | ||||
| Grant | Oct 30, 2025 | ||||
| Grant | Oct 15, 2024 | ||||
| Grant | Aug 9, 2022 | ||||
| Grant | Jan 20, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 30, 2025
Secured $3M in grant funding.
- Oct 30, 2025
Secured $40K in grant funding.
For institutional investors. Book with your work email.
Plumeria Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Plumeria Therapeutics, Inc.'s valuation, stock price, and market status.
Is Plumeria Therapeutics, Inc. a public or private company?
Plumeria Therapeutics, Inc. is a private company.
What is the current stock price of Plumeria Therapeutics, Inc.?
Plumeria Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Plumeria Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Plumeria Therapeutics, Inc. worth (valuation)?
Valuation information for Plumeria Therapeutics, Inc. is not publicly available.
Can I buy Plumeria Therapeutics, Inc. stock?
Plumeria Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Plumeria Therapeutics, Inc.'s last funding round?
Plumeria Therapeutics, Inc.'s most recent funding round was Grant on October 30, 2025.
Who are the main investors in Plumeria Therapeutics, Inc.?
Investor information for Plumeria Therapeutics, Inc. is not publicly disclosed.
Will Plumeria Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Plumeria Therapeutics, Inc..
How can I track Plumeria Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Plumeria Therapeutics, Inc.'s shares on secondary markets.